arformoterol Nebuliser solution 15 mcg - 2 ml

Established in 1993, this manufacturer employs over 1,100 staff and operates advanced production lines for metered dose inhalers, nasal sprays, dry powder inhalers, and nebulizer solutions. As a CTD dossier owner and manufacturer, it holds GMP approvals from more than 20 countries, including Australia. The manufacturer is recognized as a CTD dossier owner and manufacturer, and its products are distributed in over 90 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-end generic drugs